The Healthy Cookie Energy Study: Understanding How Healthy Cookies Affect Mitochondrial Biology

Overview

The proposed research is an intervention and feasibility pilot trial designed to determine if short-term consumption of healthy cookies made with an oil rich in linoleic acid can influence mitochondria biology in white blood cells and muscle. The hypothesis of the study is that consuming 1 healthy cookie rich in linoleic acid each day for two weeks will improve mitochondrial biology in white blood cells and muscle.

Full Title of Study: “THE HEALTHY COOKIE ENERGY STUDY: Understanding How Healthy Cookies Affect Mitochondrial Biology”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: December 1, 2024

Detailed Description

Linoleic acid has many health benefits including altering body composition and energy metabolism, possibly through its impact on cardiolipin and mitochondria. The investigators plan to test the central hypothesis and accomplish the overall objective of this research by pursuing the following four specific aims Aim 1) To assess muscle biopsy yield with a micro biopsy needle Aim 2) To determine the amount of peripheral blood mononuclear cells (PBMC) and muscle needed to measure mitochondria function Aim 3) To assess the feasibility of measuring mitochondria function on fresh PBMC and muscle samples Aim 4) To determine the effect of short-term healthy cookies made with linoleic acid rich oil on measures of mitochondrial function in white blood cells and muscle as well as their relationship to lipid composition of the blood, markers of metabolic health and markers of mitochondria biogenesis

Interventions

  • Other: High Linoleic Acid Healthy Cookies
    • High Linoleic Acid Healthy Cookies (containing about 10g of grapeseed oil) 1 per day for 2 weeks

Arms, Groups and Cohorts

  • Experimental: Healthy Cookie Group
    • All participants in the study

Clinical Trial Outcome Measures

Primary Measures

  • Changes in mitochondria function
    • Time Frame: Week 0 to Week 2
    • Mitochondria function measured in peripheral blood mononuclear cells and skeletal muscle
  • Changes in cardiolipin species
    • Time Frame: Week 0 to week 2
    • Cardiolipin species in peripheral blood mononuclear cells and skeletal muscle
  • Correlation of mitochondrial biology in blood and skeletal muscle
    • Time Frame: Week 0 and week 2
    • Correlation of mitochondria function and cardiolipin species in peripheral blood mononuclear cells and skeletal muscle

Secondary Measures

  • Changes in fasting fatty acid levels
    • Time Frame: Week 0 to week 2
    • Linoleic acid content of fasting blood samples
  • Correlation of fatty acids with mitochondrial function and cardiolipin species
    • Time Frame: Week 0 and week 2
    • Correlation of linoleic acid in blood with mitochondria function and cardiolipin species in peripheral blood mononuclear cells and skeletal muscle
  • Correlation of cardiolipin with global sleep quality score, Cambridge physical activity index and dietary intake of omega-3 fats
    • Time Frame: Week 0 and week 2
    • Correlation of cardiolipin in peripheral blood mononuclear cells and skeletal muscle with measurements of sleep quality using the Pittsburgh Sleep Quality Index, physical activity using the Epic Physical activity short questionnaire and dietary omega-3 intake using the Omega-3 Checklist
  • Correlation of cardiolipin with body mass index, sagittal diameter (abdominal thickness), walking speed and grip strength
    • Time Frame: Week 0 and week 2
    • Correlation of cardiolipin in peripheral blood mononuclear cells and skeletal muscle with measurements of body mass index, sagittal diameter, grip strength and gait speed

Participating in This Clinical Trial

Inclusion Criteria

  • Nonsmoker Exclusion Criteria:

  • Allergy/intolerance to lidocaine – Gastrointestinal diseases or disorders (including pancreatic) or gastric bypass surgery – Food Allergy or Intolerance – Any dietary restriction where consumption of these healthy cookies or any ingredient would be contraindicated – Use of medications where consuming the healthy cookies would be contraindicated – Pregnancy – Use of anticoagulant, antiplatelet, or other blood thinner medications – Diabetes

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Ohio State University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Martha Belury, Associate Professor – Ohio State University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.